Literature DB >> 30196252

X linked Charcot-Marie-Tooth disease and multiple sclerosis: emerging evidence for an association.

Georgios Koutsis1, Marianthi Breza2, Georgios Velonakis3, John Tzartos4, Dimitrios Kasselimis5,6, Chrisoula Kartanou2, Efstratios Karavasilis3, Dimitrios Tzanetakos4, Maria Anagnostouli4, Elisavet Andreadou4, Maria-Eleftheria Evangelopoulos4, Constantinos Kilidireas4, Constantin Potagas5, Marios Panas2, Georgia Karadima2.   

Abstract

OBJECTIVE: X linked Charcot-Marie-Tooth disease (CMTX) is a hereditary neuropathy caused by mutations in GJB1 coding for connexin-32, a gap junction protein expressed in Schwann cells, but also found in oligodendrocytes. Four patients with CMTX developing central nervous system (CNS) demyelination compatible with multiple sclerosis (MS) have been individually published. We presently sought to systematically investigate the relationship between CMTX and MS.
METHODS: Over 20 years, 70 consecutive patients (36 men) with GJB1 mutations were identified at our Neurogenetics Unit, Athens, Greece, and assessed for clinical features suggestive of MS. Additionally, 18 patients with CMTX without CNS symptoms and 18 matched controls underwent brain MRI to investigate incidental findings. Serum from patients with CMTX and MS was tested for CNS immunoreactivity.
RESULTS: We identified three patients with CMTX who developed clinical features suggestive of inflammatory CNS demyelination fulfilling MS diagnostic criteria. The resulting 20-year MS incidence (4.3%) differed significantly from the highest background 20-year MS incidence ever reported from Greece (p=0.00039). The search for incidental brain MRI findings identified two CMTX cases (11%) with lesions suggestive of focal demyelination compared with 0 control. Moreover, 10 cases in the CMTX cohort had hyperintensity in the splenium of the corpus callosum compared with 0 control (p=0.0002). No specific CNS-reactive humoral factors were identified in patients with CMTX and MS.
CONCLUSIONS: We have demonstrated a higher than expected frequency of MS in patients with CMTX and identified incidental focal demyelinating lesions on brain MRI in patients with CMTX without CNS symptoms. This provides circumstantial evidence for GJB1 mutations acting as a possible MS risk factor. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  CNS demyelination; Charcot-Marie-Tooth; GJB1; connexin-32; multiple sclerosis

Mesh:

Substances:

Year:  2018        PMID: 30196252     DOI: 10.1136/jnnp-2018-319014

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  2 in total

1.  Structural and functional brain changes in X-linked Charcot-Marie-Tooth disease: insights from a multimodal neuroimaging study.

Authors:  Georgios Koutsis; Georgios Velonakis; Efstratios Karavasilis; Foteini Christidi; Eirini Pantou; Georgia Angelopoulou; Dimitrios Kasselimis; Marianthi Breza; Zoi Kontogeorgiou; Dimitrios Filippiadis; Constantin Potagas; Georgia Karadima
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

2.  Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes.

Authors:  Kleita Michaelidou; Ioannis Tsiverdis; Sophia Erimaki; Dimitra Papadimitriou; Georgios Amoiridis; Alexandros Papadimitriou; Panayiotis Mitsias; Ioannis Zaganas
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.